symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
NXNN,0.0001,6.998617,14,78625,0,1.0E-4-0.15005,0,Nexeon MedSystems Inc.,USD,,,,Other OTC,PNK,Medical Devices,https://www.nexeonmedsystems.com,"Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.","Mr. William  Rosellini J.D., M.B.A., M.S., MBA",Healthcare,US,62,844-919-9990,1910 Pacific Avenue,Dallas,TX,75201,,0,https://financialmodelingprep.com/image-stock/NXNN.png,2017-09-27,True,False,False,False,False
